This brand name is authorized in Nigeria
The drug MALCLOX contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Ampicillin
UNII HXQ6A1N7R6 - AMPICILLIN TRIHYDRATE
|
|
Ampicillin is a broad spectrum penicillin, indicated for the treatment of a wide range of bacterial infections caused by ampicillin sensitive organisms. |
|
2
Cloxacillin
UNII 65LCB00B4Y - CLOXACILLIN SODIUM
|
|
Cloxacillin is a semi-synthetic beta-lactamase resistant penicillin with activity against gram-negative and gram-positive bacteria including beta-lactamase producing staphylococci. Cloxacillin acts by interfering with the formation of new bacterial cell wall by dividing organisms. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J01CR01 | Ampicillin and enzyme inhibitor | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CR Combinations of penicillins, incl. beta-lactamase inhibitors |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: NG | Registered Drug Product Database | Identifier(s): A11-1054 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
